Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
about
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasSuccessful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumorsA pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivoPreimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.Hematopoietic stem cell transplantation activity and trends at a pediatric transplantation center in Turkey during 1998-2008.Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.Reviewing the follow-up care of pediatric patients' status post-hematopoietic stem cell transplantation for the primary care pediatrician.HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors.Single-centre study reports a 84% five-year overall survival rate for paediatric solid tumours.Autologous stem cell transplantation as first line treatment after incomplete excision of pancreatoblastoma.Peripheral blood stem cell collection in low-weight children: retrospective comparison of two apheresis devices.Pediatric apheresis with a novel apheresis device with electronic interface control.The dawn of "immune-revolution" in children: early experiences with checkpoint inhibitors in childhood malignancies.Successful collection of peripheral blood stem cells upon VIDE chemomobilization in sarcoma patients.A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients.A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant.
P2860
Q35683306-E0E797B2-B1F2-4AE5-B6A4-1FDD732849C9Q36398704-09E37071-F2A8-4202-BB4B-D4AABC74C918Q36800194-6D6FC216-3074-4FBB-B1E9-2143E021C3ADQ37029379-315A362C-9B5E-4645-83E7-4D198D133FCFQ37482548-D6F30A01-C505-474B-9497-AAB7E2B2E023Q37703126-F5EE2249-B145-47FE-8C18-85A8F2E3C49CQ37719395-2AFA4AE0-F136-4991-BDA2-5C3798C0C022Q38096959-86C7E5A4-0297-4223-931A-4E403744806FQ38912245-2126DDF3-380B-4EED-B82D-F6E5748D5A14Q40810017-622437C4-03C5-4E9A-92C8-82AA3DA689E3Q41502381-07FB77B0-BBB9-4B23-B673-D66475083596Q44899898-9EA63C25-FC97-4B17-9420-0C1A1E630CEEQ46428990-29000C4C-5580-41D6-A32D-EEBCB0AE1127Q47724505-136EEE39-935A-40A4-93F0-93A186F064B4Q48015098-D5940F9B-6BA0-466B-A1BE-441F724FF4F2Q51306184-81BB87F4-A162-47F5-BF82-F62300CFCE91Q53108109-ADFC070F-94F1-4095-A7AE-885F1D5E3293
P2860
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
@en
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
@nl
type
label
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
@en
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
@nl
prefLabel
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
@en
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
@nl
P2093
P2860
P1476
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.
@en
P2093
David Barrett
Jonathan D Fish
Stephan A Grupp
P2860
P356
10.1016/J.PCL.2010.01.001
P577
2010-02-01T00:00:00Z